Prenumeration
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
As infertility reaches an alarming rate, in vitro fertilisation is seen as a beacon of hope. Despite its successes, IVF too often leads to disappointment, so innovation in the field is in high demand. Spermosens is making significant strides to address these challenges with its diagnostic technology, JUNO-Checked. BioStock spoke with recently appointed CEO Tore Duvold to learn more about the company's new strategy for bringing JUNO-Checked to the market.
Read the full article at biostock.se (https://www.biostock.se/en/):
https://www.biostock.se/en/2024/07/spermosens-helping-couples-succeed-in-babymaking/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se